POTIGA (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the POTIGA drug offered from GlaxoSmithKline LLC. This Potassium Channel Openers [MoA],Potassium Channel Opener [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | ezogabine |
| SUBSTANCE NAME: | EZOGABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Potassium Channel Openers [MoA],Potassium Channel Opener [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-04-19 |
| END MARKETING DATE: | 2019-07-31 |
POTIGA HUMAN PRESCRIPTION DRUG Details:
| Item Description | POTIGA from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: | CV
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2012-04-19 |
| END MARKETING DATE: | 2019-07-31 |
| PRODUCT ID: | 0173-0810_efb88eb8-a497-4139-bc4f-865fd499d88d |
| PRODUCT NDC: | 0173-0810 |
| APPLICATION NUMBER: | NDA022345 |
Other EZOGABINE Pharmaceutical Manufacturers / Labelers:
